Bookmark
Forward
Editorial Comment: Abiraterone in "High-" and "Low-risk" Metastatic Hormone-sensitive Prostate Cancer.
Felipe Lott
International braz j urol : official journal of the Brazilian Society of Urology 2021 Jan-Feb
Sizes of these terms reflect their relevance to your search.
No abstract available.
Citation
Felipe Lott.
Editorial Comment: Abiraterone in "High-" and "Low-risk" Metastatic Hormone-sensitive Prostate Cancer.
International braz j urol : official journal of the Brazilian Society of Urology.
2021 Jan-Feb;47(1):200-201
Mesh Tags
Androgen Antagonists
Androstenes
Hormones
Humans
Male
Prostatic Neoplasms
Substances
Androgen Antagonists
Androstenes
Hormones
abiraterone
PMID: 33047929
View Full Text